Florida Lung Health Coalition, With Support From DELFI Diagnostics, RadNet, Inc., and The American Lung Association, to Launch a Revolutionary Lung Cancer Screening Program Focused on Early Detection
RadNet, Inc. (NASDAQ:RDNT) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Radnet's Strategic Positioning in Digital Health and AI Market Drives Buy Rating
Express News | RadNet Inc : Jefferies Raises Target Price to $82 From $80
Abbott's Q3 Earnings Release Coming Up, EPD Business in Focus
RadNet Inc (RDNT) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Strategic Expansion
3 Reasons Growth Investors Will Love RadNet (RDNT)
Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating
RadNet (NASDAQ:RDNT) Shareholders Have Earned a 36% CAGR Over the Last Five Years
Optimism for RadNet (NASDAQ:RDNT) Has Grown This Past Week, Despite Five-year Decline in Earnings
Unveiling 7 Analyst Insights On RadNet
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating, Announces Target Price $80
Truist Financial analyst David S Macdonald maintains $RadNet(RDNT.US)$ with a buy rating, and sets the target price at $80.According to TipRanks data, the analyst has a success rate of 67.8% and a
Truist Financial Sticks to Their Buy Rating for Radnet (RDNT)
RadNet Is Maintained at Buy by Jefferies
Jefferies Maintains RadNet(RDNT.US) With Buy Rating, Raises Target Price to $80
Jefferies analyst Brian Tanquilut maintains $RadNet(RDNT.US)$ with a buy rating, and adjusts the target price from $75 to $80.According to TipRanks data, the analyst has a success rate of 50.9% and
Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC) and Radnet (RDNT)
Express News | RadNet Inc : Jefferies Raises Target Price to $80 From $75
S&P 500 Futures Climb In Premarket Trading; Intel, Icahn Enterprises Lead
Barclays Maintains RadNet(RDNT.US) With Buy Rating, Maintains Target Price $79
Barclays analyst Andrew Mok CFA maintains $RadNet(RDNT.US)$ with a buy rating, and maintains the target price at $79.According to TipRanks data, the analyst has a success rate of 53.8% and a total
Press Release: RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division